The Role of Continuous Ambulatory Peritoneal Dialysis in End-Stage Renal Failure Due to Multiple Myeloma

Keyphrases

• Agent-based 20%
• Alkylating Agents 20%
• Antibiotic Therapy 20%
• Bleeding 20%
• Blood Transfusion Requirement 20%
• Bone Marrow 20%
• Catheter 20%
• Central Nervous System 20%
• Chemotherapy 40%
• Chronic Dialysis 20%
• Continuous Ambulatory Peritoneal Dialysis 100%
• Dialysis 20%
• End-stage Renal Failure 100%
• Fluid Control 20%
• Gastrointestinal Tract 20%
• Gram-positive 20%
• Hematological Response 40%
• Hemodialysis 40%
• High Incidence 20%
• Intraperitoneal Antibiotics 20%
• Multiple Ends 20%
• Multiple Myeloma 100%
• Myeloma 40%
• Neutropenia 40%
• Non-responders 20%
• Peritonitis 80%
• Poor Prognosis 20%
• Preferred Mode 20%
• Septicemia 40%
• Staphylococcus 20%
• Subclavian Vein 20%
• Supression 20%
• Thrombocytopenia 20%

Medicine and Dentistry

• Alkylating Antineoplastic Agent 20%
• Antibiotic Therapy 20%
• Bleeding 20%
• Blood Transfusion 20%
• Central Nervous System 20%
• Chemotherapy 40%
• Continuous Ambulatory Peritoneal Dialysis 100%
• End Stage Renal Disease 100%
• Gastrointestinal Tract 20%
• Hemodialysis 40%
• Multiple Myeloma 100%
• Myeloma 40%
• Neutropenia 40%
• Peritonitis 80%
• Septicemia 40%
• Staphylococcus Aureus 20%
• Subclavian Vein 20%
• Thrombocytopenia 20%

Nursing and Health Professions

• Alkylating Agent 20%
• Antibiotic Therapy 20%
• Bleeding 20%
• Blood Transfusion 20%
• Chemotherapy 40%
• Continuous Ambulatory Peritoneal Dialysis 100%
• End Stage Renal Disease 100%
• Hemodialysis 40%
• Multiple Myeloma 100%
• Myeloma 40%
• Neutropenia 40%
• Peritonitis 80%
• Septicemia 40%
• Subclavian Vein Catheter 20%
• Thrombocytopenia 20%